WARREN, N.J., July 29, 2019 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. AQST, a specialty pharmaceutical company focused on developing and commercializing differentiated products that meet patients' unmet needs and solve therapeutic problems, today announced that management will present at the 2019 Wedbush PacGrow Healthcare Conference to be held in New York, NY on August 13-14. Aquestive will present on Tuesday, August 13th at 9:45 am EDT.
A webcast of the presentation will be available on the "Events and Presentation" page of the Investors section of the Company's website. A replay of each webcast will be available for 90 days following the event. For more information, please visit investors.aquestive.com.
About Aquestive Therapeutics
Aquestive Therapeutics is a specialty pharmaceutical company that applies innovative technology to solve therapeutic problems and improve medicines for patients. Aquestive is advancing a late-stage proprietary product pipeline to treat CNS conditions and provide alternatives to invasively-administered standard of care therapies. The Company also collaborates with pharmaceutical partners to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm®, and has proven capabilities for drug development and commercialization.
Media inquiries:
Christopher Hippolyte
christopher.hippolyte@syneoshealth.com
212-364-0458
Investor inquiries:
Stephanie Carrington
stephanie.carrington@icrinc.com
646-277-1282
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.